An evaluation of anti-TNF-alpha-therapy in patients with ankylosing spondylitis: imbalanced activation of NF kappa B subunits in lymphocytes and modulation of serum cortisol concentration.
Eggert, Martin
An evaluation of anti-TNF-alpha-therapy in patients with ankylosing spondylitis: imbalanced activation of NF kappa B subunits in lymphocytes and modulation of serum cortisol concentration. [electronic resource] - Rheumatology international Jul 2007 - 841-6 p. digital
Publication Type: Clinical Trial; Journal Article
0172-8172
10.1007/s00296-007-0303-z doi
Adult
Aged
Antibodies, Monoclonal--administration & dosage
Antirheumatic Agents--administration & dosage
Biomarkers--analysis
C-Reactive Protein--drug effects
DNA-Binding Proteins--drug effects
Female
Humans
Hydrocortisone--blood
Infliximab
Interleukin-6--blood
Lymphocytes--drug effects
Male
Middle Aged
NF-kappa B--drug effects
NF-kappa B p50 Subunit--drug effects
Spondylitis, Ankylosing--blood
Transcription Factor RelA--drug effects
Transcriptional Activation--drug effects
Tumor Necrosis Factor-alpha--antagonists & inhibitors
An evaluation of anti-TNF-alpha-therapy in patients with ankylosing spondylitis: imbalanced activation of NF kappa B subunits in lymphocytes and modulation of serum cortisol concentration. [electronic resource] - Rheumatology international Jul 2007 - 841-6 p. digital
Publication Type: Clinical Trial; Journal Article
0172-8172
10.1007/s00296-007-0303-z doi
Adult
Aged
Antibodies, Monoclonal--administration & dosage
Antirheumatic Agents--administration & dosage
Biomarkers--analysis
C-Reactive Protein--drug effects
DNA-Binding Proteins--drug effects
Female
Humans
Hydrocortisone--blood
Infliximab
Interleukin-6--blood
Lymphocytes--drug effects
Male
Middle Aged
NF-kappa B--drug effects
NF-kappa B p50 Subunit--drug effects
Spondylitis, Ankylosing--blood
Transcription Factor RelA--drug effects
Transcriptional Activation--drug effects
Tumor Necrosis Factor-alpha--antagonists & inhibitors